Transaction #18058 · Form 4 · 0001628280-25-056310
Strata Critical Medical, Inc. · Purchase · Class A common stock, $0.0001 par value per share
Strata Critical Medical, Inc. · Transacted December 9, 2025 · Filed December 10, 2025
What does this filing report?
An SEC Form 4 filing for Strata Critical Medical, Inc. records a purchase involving Class A common stock, $0.0001 par value per share on December 9, 2025. The reported quantity was 17,000. The filing date is December 10, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0001779128
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 17,000
- Reported price
- 4.4732 · See footnotes
- Reference value
- 76,044.4
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 1,403,436
- Ownership description
- Not reported
- SEC acceptance time
- Dec 10, 2025, 4:15 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Heyburn William A. ↗
Co-CEO and CFO · Director
CIK 0001859732
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- The reporting person realized short-swing profits under Section 16(b) of the Exchange Act as a result of transactions reported on this Form 4. On December 10, 2025, the reporting person disgorged to the Issuer the Section 16(b) short-swing profits realized by the reporting person from such transactions.
- F2
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.45 to $4.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.